Open Access

Grifolin induces apoptosis and promotes cell cycle arrest in the A2780 human ovarian cancer cell line via inactivation of the ERK1/2 and Akt pathways

  • Authors:
    • Hong Yan
    • Xiaoxia Che
    • Qingtao Lv
    • Lili Zhang
    • Samina Dongol
    • Yilin Wang
    • Hengzi Sun
    • Jie Jiang
  • View Affiliations

  • Published online on: April 25, 2017     https://doi.org/10.3892/ol.2017.6092
  • Pages: 4806-4812
  • Copyright: © Yan et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Grifolin, a secondary metabolic product isolated from the mushroom Albatrellus confluence, has been demonstrated to possess antitumor activities in a variety of malignant cells. However, the signaling pathways and the molecular mechanisms underlying the anticancer effects of the agent in human ovarian cancer remain to be elucidated. The aim of the present study was to examine the effect of grifolin treatment on the human ovarian cancer cell line, A2780. MTT and flow cytometry analysis were used to analyze the viability of A2780 cells following treatment with grifolin. Western blotting was used analyze the expression of apoptosis‑associated and cell cycle arrest‑associated proteins. The results of MTT assays and flow cytometry analysis revealed that grifolin suppressed cell viability, induced apoptosis and triggered cell cycle arrest. Western blotting revealed that grifolin treatment resulted in inactivation of protein kinase B (Akt) and extracellular signal‑related kinase 1/2 (ERK1/2), accompanied by upregulation of Bcl‑2 associated X, apoptosis regulator, cleaved‑caspase‑3 and cleaved‑poly (ADP‑ribose) polymerase, and downregulation of B cell lymphoma‑2, cyclin dependent kinase 4 and cyclinD1. The results of the present study indicated that grifolin had significant anti-cancer effects on the human ovarian cancer A2780 cells, which occurred via the Akt and ERK1/2 signaling pathways to at least a certain extent. These results demonstrate the therapeutic potential of grifolin as a treatment for ovarian cancer.
View Figures
View References

Related Articles

Journal Cover

June-2017
Volume 13 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Yan H, Che X, Lv Q, Zhang L, Dongol S, Wang Y, Sun H and Jiang J: Grifolin induces apoptosis and promotes cell cycle arrest in the A2780 human ovarian cancer cell line via inactivation of the ERK1/2 and Akt pathways. Oncol Lett 13: 4806-4812, 2017.
APA
Yan, H., Che, X., Lv, Q., Zhang, L., Dongol, S., Wang, Y. ... Jiang, J. (2017). Grifolin induces apoptosis and promotes cell cycle arrest in the A2780 human ovarian cancer cell line via inactivation of the ERK1/2 and Akt pathways. Oncology Letters, 13, 4806-4812. https://doi.org/10.3892/ol.2017.6092
MLA
Yan, H., Che, X., Lv, Q., Zhang, L., Dongol, S., Wang, Y., Sun, H., Jiang, J."Grifolin induces apoptosis and promotes cell cycle arrest in the A2780 human ovarian cancer cell line via inactivation of the ERK1/2 and Akt pathways". Oncology Letters 13.6 (2017): 4806-4812.
Chicago
Yan, H., Che, X., Lv, Q., Zhang, L., Dongol, S., Wang, Y., Sun, H., Jiang, J."Grifolin induces apoptosis and promotes cell cycle arrest in the A2780 human ovarian cancer cell line via inactivation of the ERK1/2 and Akt pathways". Oncology Letters 13, no. 6 (2017): 4806-4812. https://doi.org/10.3892/ol.2017.6092